Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Forest Laboratories and Allergy Asthma Research Institute have joined SAFE-BioPharma Association to have access to the SAFE-BioPharma digital identity and signature standard for the verification and management of digital identities involved in electronic transactions and to apply digital signatures to electronic documents.
Subscribe to our email newsletter
The pact also allows both the parties to get access to SAFE-BioPharma interoperable digital identity credentials which is a form of software installed on a computer, cell phone or other device which establishes a close link with the user’s proven identity and allows for the application of legally binding, digital signatures to electronic documents.
SAFE-BioPharma Association president and CEO Mollie Shields-Uehling said Forest Laboratories and the Allergy Asthma Research Institute are streamlining their systems by shifting to interoperable digital identities and digital signatures.